FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

Fishing partners


(Posted by Desinie Smith)
GRAND RAPIDS — The boys already are out on the ice. The fishing holes are drilled. The shelters are up.
Logan Nelson is 13. His brother, Jake, is 11. They know the routine.
Hunting, trapping, fishing, goose-calling — these boys are all over it. They have been doing most of this “since they could breathe,” says their dad, Roger Nelson of Cohasset. To read the rest of the article on duluthnewstribune.com click here.

Labels:


 

Scarbinsky: Courtney Taylor won't let MS slow him down


(Posted by- Desinie Smith)


Like a lot of football players, Courtney Taylor is waiting for the phone to ring because, at the moment, he’s a man without a team.
Auburn’s all-time leading receiver was one of the last players cut by the Seattle Seahawks on the eve of the 2009 season, and he didn’t catch on with any other organization during the season.

Labels: ,


 

Skier inspires fundraising efforts for MS


( Posted by- Desinie Smith)

In early February, Sandpoint resident Peter Faletto was saddened to hear of the death of one of his greatest heroes, Jimmie Heuga.
Huega was a man who influenced Faletto in both his personal and professional life, and it is Heuga who Faletto will honor March 13 by raising funds in his memory and donating them to a cause to which Heuga devoted his life.

Labels:


 

DisabledDiscounts.com Helps Find, Get Savings

( Posted by Desinie Smith)
If you live with a disability or love someone who does, DisabledDiscounts.com may help you discover discounts on thousands of services and products, saving cash and time.
Read the rest of this helpful article here on courant.com.

 

Stem cell treatment takes mom from death's door to remission


(Posted by Desinie Smith" Although this article isn't specifically about MS , it speaks about MS being helped or even cured/in remission by stem cells.")


Jennifer Osman embraces what most of us rebuff. "Routine. I definitely appreciate the normalcy of my life," she said.
On April 1, Jennifer will celebrate a new chance at life. That day marks the close of a five-year clinical trial to treat the chronic disease that brought her to death's door. To read the rest of the article on southtownstar.com click here.

Labels:


Saturday

 

Multiple sclerosis, Italian researchers discover a possible onset mechanism for the disease

[Posted by Shirley Richardson]

A non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work. This is what a group of researchers from the Catholic University of Rome, led by Francesco Ria (Institute of General Pathology) and Giovanni Delogu (Institute of Microbiology), have explained for the first time in a recently published article on the Journal of Immunology. ....Read full report in ScienceBlog

Labels:


 

What's new for 'MS' in PubMed

[Posted by Shirley Richardson]

What role for genetics in the prediction of multiple sclerosis? - Ann Neurol. 2009 Nov 9;67(1):3-10. [Epub ahead of print] in PubMed

Goal disengagement and goal re-engagement among multiple sclerosis patients: Relationship to well-being and illness representation. - Psychol Health. 2009 Feb;24(2):175-86. in PubMed

Summary of: Relationship between mercury levels in blood and urine and complaints of chronic mercury toxicity from amalgam restorations. - Br Dent J. 2010 Feb 27;208(4):162-3. in PubMed

The role of outcome expectations and self-efficacy in explaining physical activity behaviors of individuals with multiple sclerosis. - Behav Med. 2010 Jan-Mar 1;36(1):7-11. in PubMed

Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series. - Cases J. 2009 Aug 6;2:6609. in PubMed

The influence of corrected visual acuity on visual attention and incidental learning in patients with multiple sclerosis. - Appl Neuropsychol. 2009 Jul;16(3):165-8. in PubMed

Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders. - Interdiscip Perspect Infect Dis. 2010;2010:273573. Epub 2010 Feb 21. in PubMed

Rehabilitation challenges in multiple sclerosis. - Ann Indian Acad Neurol. 2009 Oct;12(4):296-306, in PubMed

The symptomatic management of multiple sclerosis. - Ann Indian Acad Neurol. 2009 Oct;12(4):291-5. in PubMed

Promising treatments of tomorrow for multiple sclerosis. - Ann Indian Acad Neurol. 2009 Oct;12(4):283-90. in PubMed

Disease-modifying agents in multiple sclerosis. - Ann Indian Acad Neurol. 2009 Oct;12(4):273-82. in PubMed

Management of acute exacerbations in multiple sclerosis. - Ann Indian Acad Neurol. 2009 Oct;12(4):264-72. in PubMed

Labels:


Friday

 

ASA: Video Games May Aid Stroke Recovery


(Posted by Desinie Smith " I've heard and read that the Nintendo Wii can help with certain multiple sclerosis symptoms such as balance and cognition although, I have no personal experience with this with which to corroborate.")


Playing Nintendo's Wii improved motor function in patients who had suffered a stroke, without causing any safety concerns,a small, proof-of-principle study showed.

Read the rest of the article here.

Labels:


 

Multiple Sclerosis: A Breakthrough Is on the Way


(Posted by Desinie Smith)

A number of improved treatments will be available soon, and Novatis' Fingolimod could lead the way


Bullock is in " the best shape I've been in for years" thanks to Fingolimod. When Thomas Bullock was diagnosed with multiple sclerosis in 2001, several new treatments for the incurable , nerve-destroying condition had just hit the market. The automotive worker from Ontario spent two years on Bayer's blockbuster Betaseron, an injectable drug that can suppress a hyperactive immune system. But instead of getting better,Bullock endured constant flu-like

symptoms and numbness in his limbs. When he developed severe nerve damage,he ditched the injections. " My body just couldn't handle it," recalls Bullock , now 41.

To read the rest of the article on businessweek.com click here.

Labels: ,


Thursday

 

Rocky Mountain MS Center and Clinical Trials


( Posted by Desinie Smith )

The Rocky Mountain MS Center sends out free bi-weekly newsletters to your e-mail just by signing up. The latest e-newsletter has info on CCSVI, acupuncture, and several different clinical trials. To read on their site click here.

To sign up for their e-newsletters click here.


Also the site where you can keep up with and sign up for MS related clinical trials is http://www.clinicaltrials.gov/

 

Drug helps MS patients with mobility problems


(Posted by Desinie Smith- ("At $1,000 a month this may be an obstacle in getting insurance companies to approve it. I like that there's a video along with this article showing someone who's been on it for the past 6 years (through the clinical trials) walking better."-Desinie )


Trouble walking is one of the biggest challenges faced by people with the neurological disease multiple sclerosis.

The Food and Drug Administration recently approved an oral medication to help people improve their walking speed - an encouraging development in the MS community.


To read the rest of the article and see the video on abclocal.go.com click here.

Wednesday

 

Man biking across America for multiple sclerosis


( Posted by Desinie Smith)

Ask Thomas Beasley where he lives, and he really can't give a good answer. Originally from Anaheim, California, Beasley has spent almost two decades --for an average length of 10 months per year--atop his bicycle, cycling from one end of the country to the other to raise money and awareness for multiple sclerosis.

Despite being his 58th trip across the U.S., this is only his second time through Macon. This visit is about 17 years after his first trip to Macon. Beasley, 41, began his peripatetic journey 19 years, one month and 23 days ago as a tribute to a friend named John Toodle. In 1989, Beasley was training for the Tour de France , biking across America as part of his preparations.

To read the rest of the article on macon.com click here.

Labels: ,


 

Neurologists on Facebook?

( Posted by Desinie Smith)
The advent of low cost and near-instantaneous communication on the internet has spawned a number of popular social media websites such as Facebook,Myspace and Twitter. These sites provide an informal international forum for people to share personal and professional information. Popular topics range from golf and wine to the more esoteric, such as railroads and medieval history. Physicians can discuss medical news, challenging clinical cases,business management and even market their practices.
To read the rest of the article on
boards.medscape.com click here.

Labels:


 

NMSS Video on Ampyra,New MS "Walking" Drug

( Posted by Desinie Smith)
The National Multiple Sclerosis Society has released a video featuring the noted neurologist Dr. Patricia Coyle, answering questions on Ampyra, a recently approved drug that's meant to increase the mobility of MS patients by increasing the conductivity of damaged nerve cells.
Click here to read the rest of the article and see the video on wheelchairkamikaze.com.

Labels:


 

For disabled, 'affordable' independent living is the ideal, but often out of reach


(Posted by Desinie Smith)


After the unveiling of a 500 page national report on housing opportunities for disabled Americans Tuesday , Harvey Raben stood,leaning on his walker to fight the effects of Multiple Sclerosis, and asked a pointed question.

" The heart of the housing question for disabled people is: Will there be more vouchers open so more people can get decent housing?"

Lynn Grosso, of the U.S. Department of Housing and Urban Development, answered: " The need far outweighs the availability."

Read the rest of the article here on news.medill.northwestern.edu

 

Visual Cues that Improve Walking for People with Movement Disorders - Study Shows Small Change in Arrangement Can Make a Big Difference in Improvement


(Posted by Desinie Smith)

It is well known that certain visual cues in the walking path can improve walking for movement disorder patients. A study performed with a augmented reality device is the first look at the significance of the visual cue chosen.

Visual feedback has been found in numerous studies to improve the walking abilities of patients with Parkinson's disease, Multiple Sclerosis, Stroke and Senile Gait.

While early studies used equally spaced transverse lines drawn on the ground, later reports noted that other visual patterns , such as checkerboard-like tile arrangement, also brings improvements.

Read the rest of the article here on prweb.com.

Labels:


 

Medical marijuana debate heats up at the Capitol-NY


(Posted by Desinie Smith)


Albany,NY

A push to allow for medical marijuana has passed a State Senate committee in hopes that the issue will come to the floor for a full Senate vote this session.

But there are serious concerns among law enforcement that the need for weed could spark new public safety problems.

Michael Kessler of Elmira broke his back in 6 places , then burned 90% of his body.

Timothy Cerrone of Amsterdam has multiple sclerosis, and needs injections to be able to see.

Read the rest of the article here on wten.com.


Labels:


 

Multiple Sclerosis: Understanding the Differences in MS

(Posted by Desinie Smith)
In some ways , each person with multiple sclerosis lives with a different illness. Although nerve damage is always involved, the pattern is unique for each individual who has MS.
Although individual experiences with MS vary widely, physicians and researchers have identified several major types of MS. The categories are important. That's because they help predict disease severity - and response to treatment.
Read the rest of the article here on webmd.com.

Tuesday

 

Fargo reflects on life since Sacramento mayor job


( Posted by Desinie Smith)


Heather Fargo did not have the luxury of easing reflectively into life as a private citizen. Just a few weeks after she packed her office at City Hall in November 2008, ending nearly two decades of service as a councilwoman and mayor, Fargo learned she had breast cancer.

To read the rest of this inspiring article which includes Heather Fargo's MS struggles on sacbee.com click here.

Labels:


 

Adeona Announces Completion of 50% Enrollment in Trimesta(TM) Multiple Sclerosis Clinical Trial

(Posted by Desinie Smith)
Adeona Pharmaceuticals, Inc. announced today that the clinical trial of it's investigational drug Trimesta (TM) ( estriol oral) being conducted by principal investigator Dr. Rhonda Voskuhl ( Director UCLA Dept. of Neurology) has enrolled over 75 patients. The total planned enrollment is 150 patients.
The Trimesta (TM) study is a double-blind, placebo-controlled clinical trial. Sixteen sites in the United States are currently enrolling patients. Investigators at these clinical sites are administering either Trimesta (TM) along with glatimer acetate (Copaxone) , to women between the ages of 18 to 50 who have been recently diagnosed with relapsing-remitting multiple sclerosis.
Read the rest of the article here on marketwatch.com.

Labels: ,


 

Evaluating Neurological Symptoms


(Posted by Desinie Smith)




In massage therapy, the tendency is to focus on the role of muscles in pain or injury,sometimes to the exclusion of other soft tissues. Nerves are one of these often forgotten tissues, yet they play a critical role in many pain complaints. Neglecting these tissues can lead to inadequate treatment and the development of chronic pain conditions.


With all the work we perform on soft tissues throughout the body, the absence of knowledge of nerve-tissue disorders is serious. Read the rest of the article here on massagetoday.com.

Labels:


 

MS Drug Ampyra Gets FDA Nod

[Posted by Shirley Richardson]

Ampyra Improves Walking in Many Multiple Sclerosis Patients

Jan. 22, 2010 - The FDA has approved Ampyra (dalfampridine), which improves walking ability in adults with multiple sclerosis (MS). ...Read the full report in WebMD

Labels: ,


 

How Aggressive Cells Invade The Brain: Real-Time Observation Sheds New Light On Multiple Sclerosis


[Posted by Shirley Richardson]

ScienceDaily (Nov. 6, 2009) — In diseases such as multiple sclerosis, cells of the immune system infiltrate the brain tissue, where they cause immense damage. For many years, it was an enigma as to how these cells can escape from the bloodstream. This is no trivial feat, given that specialized blood vessels act as a barrier between the nervous system and the bloodstream. Until now, tissue sections provided the sole evidence that the immune cells really do manage to reach the nerve cells. ....Read the full report in ScienceDaily


Labels:


 

What's new for 'MS' in PubMed

[Posted by Shirley Richardson]

Substrain Differences Reveal Novel Disease-Modifying Gene Candidates That Alter the Clinical Course of a Rodent Model of Multiple Sclerosis. - J Immunol. 2010 Feb 19. [Epub ahead of print] in PubMed

Swine flu vaccine adjuvants and multiple sclerosis - Is there potential for harmful effect? - ed Hypotheses. 2010 Feb 18. [Epub ahead of print] in PubMed

Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis. -J Neuroimmunol. 2010 Feb 18. [Epub ahead of print] in PubMed

Under Treatment of Overactive Bladder Symptoms in Patients With Multiple Sclerosis: An Ancillary Analysis of the NARCOMS Patient Registry. - J Urol. 2010 Feb 19. [Epub ahead of print] in PubMed

[Pathophysiology of multiple sclerosis.] - Presse Med. 2010 Feb 17. [Epub ahead of print] in PubMed

Combination therapy in multiple sclerosis. - Lancet Neurol. 2010 Mar;9(3):299-308. in PubMed

Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan. - Can J Neurol Sci. 2010 Jan;37(1):28-35. in PubMed

Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients. - Mult Scler. 2010 Feb 18. [Epub ahead of print] in PubMed

Does MRI lesion activity regress in secondary progressive multiple sclerosis? - Mult Scler. 2010 Feb 18. [Epub ahead of print] in PubMed

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study. - Mult Scler. 2010 Feb 18. [Epub ahead of print] in PubMed

The past, present and future of imaging in multiple sclerosis. - J Clin Neurosci. 2010 Feb 16. [Epub ahead of print] in PubMed

Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice: II. CNS disease severity. - J Neuroimmunol. 2010 Feb 16. [Epub ahead of print] in PubMed

Labels:


 

Chairman Bill Young: Next Biogen Idec CEO May Be a Scientist

[Posted by Shirley Richardson]

The future leader of Biogen Idec might be as familiar with a petri dish as he or she is with a spreadsheet.

That’s according to Bill Young, who took over as Biogen’s chairman of the board on January 1. Young is on the board committee that’s searching to replace CEO Jim Mullen, who announced last month that he’s stepping down after a decade at the helm of the Cambridge, MA-based biotech giant (NASDAQ: BIIB). I met with Young last week while he was visiting a startup in Seattle. ....Read the full story in Xconomy Boston

Labels:


 

Kingman woman tells her addiction story on TV

[Posted by Shirley Richardson]

(AP) — KINGMAN, Ariz. - Leanna Long says she told her story of pain pill addiction because she didn't want to hide from it anymore.

"At first I said no," the 27-year-old mother of two said.

"This was the most humiliating, humbling experience of my life and you want me to share that on television?"

Read the full story in PennLive.com

Labels:


Monday

 

Novartis oral multiple sclerosis development compound Gilenya®* (FTY720) granted US priority review status


(Posted by Desinie Smith)

Novartis International AG/ Novartis oral multiple sclerosis development compound Gilenya (FTY720) granted US priority review status processed and transmitted by Hugin AS. The isuer is solely responsible for the content of this announcement.

* US Food and Drug Administration grants priority review status after accepting US regulatory for 0.5 mg once-daily Gilenya ( fingolimod)

To read the rest of the article on pr-inside.com click here.

Labels:


 

Happy People May Have Better Heart Health


(Posted by Desinie Smith)


Individuals who find joy, excitement and contentment in their daily lives may be protected from cardiovascular disease, researchers found. Higher levels of positive affect, a measure of happiness, were associated with a significantly lower risk of having a cardiovascular event over a 10-year period according to Karina Davidson, PhD, of Columbia University Medical Center in New York City, and colleagues.

Read the rest of the article here on medpagetoday.com.


 

AAN: Migraine Linked to MS in Women


( Posted by Desinie Smith)


Women with physician-diagnosed migraine appear to have an increased risk of developing multiple sclerosis (MS), researchers found.

Among female nurses,the rate of migraine was higher among those who were eventually diagnosed with multiple sclerosis than in the overall cohort (21.9% versus 15%) according to Illya Kister, MD , of NYU Langone Medical Center.

Read the rest of the article here on medpagetoday.com.

 

MS Study Links Narrow Veins to Disease



(Posted by Desinie Smith)



More than half of the multiple sclerosis patients in a closely watched study had narrowing of some neck veins leading from the brain, researchers said.

On the other hand,so did 22.4% of healthy controls in the first large study to test a new theory about the disease: that is caused by such abnormally narrowed veins , a condition dubbed "chronic cerebrospinal venous insufficiency".
Read the rest of the article
here on medpagetoday.com.

Labels:


Sunday

 

Multiple sclerosis charity urges end to drug scheme


(Posted by Desinie Smith)


The MS Society is calling on the government to scrap the scheme which offers disease- modifying drugs to some people with multiple sclerosis.

Since 2002, the scheme has enabled the NHS to prescribe the drugs while their cost- effectiveness was evaluated.

But the charity argues the study is flawed, and fears the scheme is hindering access to other therapies.

The government insists the scheme has significantly improved the overall care and support available to MS patients.

To read the rest of the article on news.bbc.co.uk click here.

 

'I had controversial MS treatment twice'


(Posted by Desinie Smith)


A team in New York has reported the first results of a trial to test the theory that restricted blood flow in the brain may underlie some of the symptoms of multiple sclerosis.

Gianfranco Campalani knows a thing of two about the vascular system. He's one of Northern Ireland's leading heart surgeons. He was diagnosed with multiple sclerosis (MS) in 1986- it left him with a series of problems in his lower body.


To read the rest of the article click here on news.bbc.co.uk.

Labels:


 

Medical Marijuana Benefits MS, Spinal Cord Patients: Report

[Posted by Shirley Richardson]

Marijuana helps ease muscle spasms caused by multiple sclerosis and pain caused by certain neurological illnesses or spinal cord injuries, says a report released Wednesday by the Center for Medicinal Cannabis Research at the University of California, San Diego. ...read report in EmpowHER

Labels:


 

Biogen discloses four more PML cases

[Posted by Shirley Richardson]

Biogen Idec officials say that four more patients have contracted a rare brain infection associated with the company’s blockbuster multiple sclerosis drug, Tysabri.

This brings the total number of cases of the infection, known as PML, to 35 since July 2008....read report in The Journal of New England Technology

Labels: Tysabri, Biogen

Labels: , , ,


 

More good news for patients awaiting MS tablet

[Posted by Shirley Richardson]

Promising results from placebo-controlled trials of two oral immunosuppressants for relapsing-remitting multiple sclerosis have been published in the New England Journal of Medicine.

The first study, FREEDOMS, tested the sphingosine-1-phosphate receptor modulator fingolimod. As previously reported on mims.co.uk, fingolimod significantly reduced the risks of relapse and disability progression during the two-year treatment period. The drug, which is being developed by Novartis, lessens nerve inflammation by effectively ‘trapping' lymphocytes in lymph nodes.

The second study, CLARITY, evaluated Merck Serono's cladribine in 1326 patients over the course of 96 weeks. Cladribine, which is already approved in the UK as an injectable treatment for leukaemia (Leustat), mimics adenosine to interfere with the processing of DNA in blood cells.....full report in healthcarerepublic
Labels: Oral Disease Modifying Drugs, Research

Labels:


 

Villagers find therapeutic riding program alleviates multiple sclerosis symptoms

[Posted by Shirley Richardson]

OCALA — To hear their stories, one might initially assume Cindy Berkovitz and Judy Heath wouldn’t be physically able to ride a horse. Both women from The Villages have multiple sclerosis and both require the use of an aid — Berkovitz a scooter and Heath a leg brace — to get around.

But these women can mount a horse and ride with confidence.

Through their grit and determination and with a little help from their friends — in this case the horses of the Marion Therapeutic Riding Association, Berkovitz and Heath, along with other area MS patients, are proof that multiple sclerosis doesn’t control an individual’s ability to do what they want. ...Read the full story in The Villages Daily Sun
Labels: Exercise, Inspiration

Labels: ,


 

What's new for 'MS' on PubMed

[Posted by Shirley Richardson]

New approaches to neuroimaging of central nervous system inflammation. - Curr Opin Neurol. 2010 Feb 17. [Epub ahead of print] in PubMed

Does MRI lesion activity regress in secondary progressive multiple sclerosis? - Mult Scler. 2010 Feb 18. [Epub ahead of print] in PubMed

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study. - Mult Scler. 2010 Feb 18. [Epub ahead of print] in PubMed

The past, present and future of imaging in multiple sclerosis. -J Clin Neurosci. 2010 Feb 16. [Epub ahead of print] in PubMed

Effect of immunmodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis - A longitudinal MRI study. - Brain Res. 2010 Feb 15. [Epub ahead of print] in PubMed

Assessment of social cognition in patients with multiple sclerosis. - JInt Neuropsychol Soc. 2010 Feb 19:1-10. [Epub ahead of print] in PubMed

Lower urinary tract dysfunction in MS: management in the community. - Br J Community Nurs. 2009 Nov;14(11):474, 476, 478-80. in PubMed

Carnitine for fatigue in multiple sclerosis. - Cochrane Database Syst Rev. 2010 Feb 17;2:CD007280. in PubMed

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence. - Patient Prefer Adherence. 2010 Feb 4;4:1-9. in PubMed

Novel MRI approaches to assess patients with multiple sclerosis. - Curr Opin Neurol. 2010 Feb 15. [Epub ahead of print] in PubMed

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. - Lancet Neurol. 2010 Feb 15. [Epub ahead of print] in PubMed

Latitudinal variation in incidence and type of first central nervous system demyelinating events. - Mult Scler. 2010 Feb 18. [Epub ahead of print] in PubMed

Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis. - J Neurol. 2010 Feb 16. [Epub ahead of print] in PubMed

Environmental factors and their timing in adult-onset multiple sclerosis. - Nat Rev Neurol. 2010 Feb 16. [Epub ahead of print] in PubMed

Cancer risk among patients with multiple sclerosis and their parents.- Neurology. 2009 Mar 31;72(13):1170-7. in PubMed

Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. - Neurology. 2010 Feb 16;74(7):545-52. in PubMed

The characterisation of gait patterns of people with multiple sclerosis. - Disabil Rehabil. 2010 Feb 15. [Epub ahead of print] in PubMed

Multi-system neurological disease is common in patients with OPA1 mutations. - Brain. 2010 Feb 15. [Epub ahead of print] in PubMed

Labels:


Saturday

 

Exercise has protective effect on brains of multiple sclerosis patients

( Posted by Desinie Smith)
Exercise is good for the brains of patients with multiple sclerosis, a new study has found. In the new study, researchers found that highly fit multiple sclerosis patients performed significantly better on tests of cognitive function than similar less fit patients.
In addition, MRI scans of the patients showed that the fitter MS patients showed less damage in parts of the brain that show deterioration as a result of the MS , as well as a greater volume of vital grey matter.

Read the rest of the article
here on dnaindia.com.

Labels:


 

New Oral MS Drug

(Posted by Desinie Smith)
Finally a drug to really help multiple sclerosis patients. Doctors here in Chicago were the first to test it back in the 1980's. This month the FDA moved to approve it...and doctors say it will help MS patients from this day forward.

"Let me see your knee reflexes..Good."
It wasn't always that way for Steve Wine. It seemed his function was bad and kept getting worse.
Read the rest of the article
here on wgntv.com.

Labels:


Friday

 

Stem cells 'able to reverse symptoms of multiple sclerosis'

(Posted by Desinie Smith)
Scientists have been able to reverse the symptoms of multiple sclerosis using stem cells from people's own body fat. Some have been left free from seizures and better able to walk after the treatment.

Researchers said that the results suggest that the "very simple" injection of their own cells can stimulate the regrowth of tissue damaged by the progression of the disease.
Read the rest of the article
here on telegraph.co.uk.

Labels:


 

Adult Stem Cells

( Posted by Desinie Smith)
Barry Goudy was diagnosed with multiple sclerosis in May 1995. Over the years the treatment became less effective.

Click here to read the rest of the article and to read more on this very informative site.
Also this story is very hopeful as well.

Labels:


 

MS pills show promise and risk, studies say

(Posted by Desinie Smith)
Tests of the first two oral drugs developed for treating multiple sclerosis show that both cut the frequency of relapses and may slow progression of the disease, but with side effects that could pose a tough decision for patients.

Click here for the full article on wsbt.com.


 

MS Awareness Week

( Posted by Desinie Smith)
MS Awareness Week is March 8 to 14th, 2010. Spread the word!

Thursday

 

Vision and Driving in Multiple Sclerosis

(Posted by Desinie Smith)
Objective:
To examine the relationship between measures of visual dysfunction and driving performance in multiple sclerosis ( MS).
Read the rest of the article
here on PubMed.gov.

 

Medical Marijuana: Putting Together California’s Research

(Posted by Desinie Smith)
After California became the first state to allow medical use of marijuana, legislators decided in 1999 to fund research that was supposed to figure out what the drug was good for therapeutically. Now we have an answer: a report issued today says it seems to ease some types of pain, and maybe muscle spasticity from multiple sclerosis.
Read the rest of the article
here on blogs.wsj.com.

Labels:


 

Seahawks mascot diagnosed with multiple sclerosis

(Posted by Desinie Smith)
One of the best known Seahawks has been keeping a difficult secret for more than a year.
You've seen "Blitz" dance with Blue Thunder and leap from the roof of Quest Field. He roams the stands on game day pumping up the crowd.

Read the rest of the article
here on mynorthwest.com.

Labels:


 

Migraine Tied to Raised Multiple Sclerosis Risk


(Posted by Desinie Smith)

But overall odds are still low and headache suffers shouldn't worry,researcher says

Migraines are more common in women with multiple sclerosis (MS) than in those without the disease, new research shows.
Read the rest of the article
here on businessweek.com.

Wednesday

 

Very Imformative Website!

( Posted by Desinie Smith)
Just wanted to pass on this website as I've found it very informative, helpful and worthy of signing up for the newsletters and/or just reading on her site. The author, Julie Stachowiak, has MS , has a Phd. and is extremely well informed on all current things MS related. Whether you are newly diagnosed or have MS for years, I feel certain you will find something that benefits you by reading on her site and signing up for her newsletters which are free.
It also can be very helpful to read under the comments section of each article where other people with MS have posted tips that they've found helpful to deal with their symptoms.
You can get to her website on about.com by clicking
here.

Tuesday

 

Bayfield climber conquers Everest and inspires others

(Posted by Desinie Smith)

A Bayfield, Wisconsin mountain climber with multiple sclerosis has reached the top of the world. Now she's taking part in a world-class event and traveling the country sharing her message of hope and perseverance. She became the first person with MS to conquer Mount Everest , an incredible feat of strength, courage and endurance. Read the rest of the article here on fox21online.com.

Labels:


 

New Criteria Proposed for Diagnosing Multiple Sclerosis

(Posted by Desinie Smith)

New Criteria Proposed for Diagnosing Multiple Sclerosis
by June Chen, M.D.

Multiple sclerosis is a debilitating disease in which the body's immune system attacks the fatty substance surrounding the nerve fibers in the brain and spinal cord. The resulting damage interferes with the transmission of nerve signals between the brain and spinal cord and other parts of the body. In the February 2010 issue of Neurology, investigators are suggesting new diagnostic criteria for multiple sclerosis.
Read the rest of the article
here on healthandage.com.

Labels:


 

Added Drug Aids MS Treatment


( Posted by Desinie Smith)

Multi-center study shows daclizumab reduces disease activity when added to interferon beta.


Adding the drug daclizumab to standard treatment with interferon beta may reduce multiple sclerosis disease activity more than interferon beta alone, a new study reports.
Previous non-randomized studies found that daclizumab -- a humanized monoclonal antibody--reduced MS disease activity.
This new phase 2 study at 51 centers in the United States, Canada, Germany,Italy and Spain included 230 patients with active relapsing MS who were taking interferon beta.
Read the full article
here on USNews.com.

Labels:


Monday

 

NARCOMS ( North American Research Committee on Multiple Sclerosis) Newsletter





( Posted by Desinie Smith)

Just passing this along as I think it's worthy of signing up for this newsletter ( and quarterly surveys) since it has a lot of great information for people with MS.

Click
here for their latest newsletter.

To sign up to receive their updated newsletters and to sign up to take their surveys which help MS research and where you can track your progression, symptoms, etc. click
here.

Labels:


 

Jimmie Heuga Changed Thinking on MS and Exercise

( Posted by Desinie Smith)
In 1964, Jimmie Heuga became one of the first Americans- along with Billy Kidd- to win an Olympic medal in Alpine skiing. In 1970, at age 26, Heuga was diagnosed with multiple sclerosis.
Back then, people with MS were counseled to curtail physical activity, which was thought to exacerbate symptoms.
Heuga didn't buy that. He chose to continue an active lifestyle, set goals, live life with passion.

Read the rest of the article
here on the Washington Post.

Labels:


Sunday

 

Doctors cautious over new MS theory

( Posted by Desinie Smith)
Albertans suffering from multiple sclerosis are optimistic that new research will shed light on the puzzling neurological disease even as many in the medical community say it's too soon to draw any conclusions about the controversial theory.
Read the rest of the article
here in the Calgary Herald.

Labels: ,


 

Listen to the Patient

( Posted by Desinie Smith)
Sometimes in this job you just get lucky. You have an elusive and/or dangerous diagnosis just dropped in your lap.

Click
here for the full article from MedPage Today.

Labels:


Saturday

 

Cooper said his condition improved immediately after the injections

( Posted by Desinie Smith)
NORTH-EAST multiple sclerosis sufferer has defended controversial treatment from a doctor who is facing a General Medical Council (GMC) misconduct hearing.

Click
here for full story.

Labels:


 

Singer Shares Multiple Sclerosis Story

( Posted by Desinie Smith)
When Carrie Smith heard the news," The good news is, it's not a brain tumor", she laughed. After all, she thought she just had a bad case of the flu.

Click
here for the full article from The Independent.

Labels:


Friday

 

High Intake of Vitamin D in Pregnant Women Lowers MS Risk

(Posted by Desinie Smith)
Women whose mothers consumed high levels of Vitamin D during pregnancy have a lower risk of developing multiple sclerosis, a large observational study confirmed.

Click
here for full story.

Labels:


Sunday

 

Cannabis Beneficial for Multiple Sclerosis Patients, Study Finds

(NaturalNews) A systematic review conducted by The Global Neuroscience Initiative Foundation found that five of six controlled trials reported a reduction in spasticity and an improvement in mobility amongst multiple sclerosis patients using cannabis extracts. ....full story in NaturalNews.com

 

More Multiple Sclerosis Drug Tysabri Warnings

Washington, DC: US health officials have warned that the multiple sclerosis drug Tysabri (generic name natalizumab) can potentially cause a fatal brain disorder and the risk is greater as patients receive more infusions.

Two weeks after European regulators announced the warning, on February 5, 2009 the FDA said the warning was based on 31 confirmed cases (including eight deaths) of progressive multifocal leukoencephalopathy (PML), a brain infection that can be fatal. Still, the FDA website states that the clinical benefits of Tysabri continue to outweigh the potential risks.

Tysabri was temporarily withdrawn from the market in 2005 because of its link to PML, but surfaced again in 2006. Since that time about 66,000 people worldwide have been treated with the drug, which is given as a single infusion every four weeks. In September the FDA said the PML rate appeared to increase with the number of infusions but said at the time it was not requiring any changes to the drug's warnings. Tysabri already carries a boxed warning regarding the PML risk.

Federal regulators have now posted a safety update to doctors and patients confirming changes made to the label of Tysabri, to warn of the higher risk with long-term use.

The manufacturer, Biogen Idec Inc., is required to updates the number of PML cases each month to doctors on request but no longer posts the figure on its website or issues a press release. ...... Report and related articles in LawyersandSettlements.com

Labels: , ,


Saturday

 

Blacks with MS Have More Severe Symptoms, Decline Faster than Whites, New Study Shows

Full news release in University of Buffalo

 

New Multiple Sclerosis treatment may end with Utah woman


SALT LAKE CITY (ABC 4 News) - At the end of November a young mother kissed her children goodbye, and boarded a flight with her husband. It was the beginning of a medical journey that she believes has ended with miraculous results. Michelle Colledge was treated for severe Multiple Sclerosis at Johns Hopkins, in Baltimore Maryland. She is just one of 44 patients to receive the experimental High Dose Cyclophosphamide, and may be the last.....full story in abc4News

 

FDA Warns of Brain Risks With Frequent Tysabri Use

Federal health officials warned doctors Friday that the risk of a deadly brain inflammation linked to the multiple sclerosis treatment Tysabri increases with use of the drug.

Tysabri has been plagued for years by rare cases of progressive multifocal leukoencephalopathy, or PML, which can cause swelling of the brain that is usually fatal. It is mostly seen in patients with immune deficiencies.

The biotech drug is marketed by Cambridge, Mass.-based Biogen Idec Inc. and Irish drugmaker Elan Corp. PLC, for multiple sclerosis and Crohn's disease.

The Food and Drug Administration said in a statement it has confirmed a total of 31 cases of PML since mid-2006. Eight of those patients have died, as of last month, according to the FDA. The agency posted updated labeling information for the drug to its Web site.

In the new labeling, FDA notes there have been no reports of PML in patients taking Tysabri for less than 12 months. In patients taking the drug for two to three years the rate of PML is one case per 1,000 patients.

The new labeling also warns of a complication of PML, known as Immune Reconstitution Inflammatory Syndrome, that can dramatically damage patients' health even after they have stopped taking Tysabri. The agency urges doctors to monitor patients for signs of inflammation.

Tysabri was approved in November 2004 and pulled from the market the next year due to PML reports. It was reintroduced in July 2006, and has been used by 66,000 people worldwide.

Shares of Biogen Idec Inc. fell 4 cents Friday to $53.06 in midday trading. Elan dipped 3 cents to $7.11.
Story in ABC News/Money

Labels: , ,


Friday

 

What's new for 'Multiple Sclerosis' in PubMed

MS characterization of qualitative protein polymorphisms in the spinal cords of inbred mouse strains. - Proteomics. 2010 Feb 3. [Epub ahead of print] - in PubMed

Multiple Sclerosis and the Accumulation of Iron in the Basal Ganglia: Quantitative Assessment of Brain Iron Using MRI T(2) Relaxometry. - Eur Neurol. 2010 Jan 30;63(3):136-143. [Epub ahead of print] - in PubMed

Prognosis of the individual course of disease: the elements of time, heterogeneity and precision. - J Neurol Sci. 2009 Dec;287 Suppl 1:S50-5. - in PubMed

Current therapeutic recommendations in multiple sclerosis. - J Neurol Sci. 2009 Dec;287 Suppl 1:S37-45. in PubMed

Knowns and unknowns in the future of multiple sclerosis treatment. - J Neurol Sci. 2009 Dec;287 Suppl 1:S30-6. in PubMed

Early treatment: PreCISe-ly what the patient needs. - J Neurol Sci. 2009 Dec;287 Suppl 1:S2-6. in PubMed

Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role. - J Neurol Sci. 2009 Dec;287 Suppl 1:S17-23. in PubMed

Health and quality of life in patients with relapsing multiple sclerosis: making the intangible tangible. - J Neurol Sci. 2009 Dec;287 Suppl 1:S11-6. in PubMed

A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes. - J Neurol Sci. 2009 Dec;287 Suppl 1:S24-9. in PubMed

Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives. - Atheroscler Suppl. 2009 Dec 29;10(5):129-132. in PubMed

Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. - Brain. 2010 Feb 3. [Epub ahead of print] in PubMed

Novel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosis. - Brain. 2010 Feb 3. [Epub ahead of print] in PubMed

 

UPDATE: FDA Approves Fampridine SR, Now Called Ampyra,™ to Improve Walking for People with All Types of MS

Full report in the National MS Society

Labels: ,


 

UPDATE: CCSVI or Blood Flow in the Brain and Venous Insufficiency in Multiple Sclerosis

Full report in the National MS Society

 

New pills for MS tested

Full story in BuryFree Press

 

AAPM: Nerve Growth Factor Antibody May Reduce Pain

 

Gordon Brown Receives Prescription Promise 'Wake-Up Call', UK

 

3-Year Mission To Understand And Treat Neurodegenerative Disease

 

The Season Affects Multiple Sclerosis Risk

 

Stan's Angels on Facebook: Here's updates on Ampyra, Fingolimod & Cladribine


(((THANK-YOU-HUGS))) TO ONE OF OUR NEW NEWS ANGELS...DESINIE, FOR SENDING THIS INFORMATION:

Stan, Here's updates on Ampyra, Fingolimod & Cladribine!

xxxx
Desine

Update: Ampyra, fingolimod and cladribine - Breaking News

Labels: ,



Go to Newer News Go to Older News